Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis. Comment on: Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept

Autor:	Castellanos-Moreira, R., Gomez, A., Isabel Haro, Ruiz-Esquide, V., Marsal, S., Sanmarti, R.
Rok vydání:	2020
Předmět:	Abatacept Arthritis Rheumatoid Rheumatology Rheumatoid Factor Immunology Immunology and Allergy Humans
Zdroj:	Publons
ISSN:	0392-856X
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72387a73dc78e505f93e59f837fb43a3 https://pubmed.ncbi.nlm.nih.gov/33686936 Zobrazit plný text záznamu